New York, NY / July 7, 2022 (Business Wire) — COTA, Inc., an oncology real-world data and analytics company, today announced the appointment of Sandy Leonard as its first Chief Commercial Officer. Sandy, a leader with more than 20 years of deep pharmaceutical and real-world data expertise, will lead COTA’s business expansion efforts during a period of strong, sustainable growth.
COTA recently announced a series of new offerings and strategic partnerships that will help support Sandy’s strategic role, including a new data partnership with the Genomic Testing Cooperative and a strategic real-world data research partnership with the Clinical Research Data Sharing Alliance. The company has a sustainable and strong track record of growth, averaging more than 50% revenue growth year-over-year since 2019. Today, COTA also works with nine of the top 10 oncology biopharma companies in the world.
As CCO, Sandy will drive COTA’s life sciences growth strategy, prioritizing customer success and experience. More specifically, she will lead a team that is laser-focused on ensuring that pharmaceutical partners have the data assets, analytics, services, and support they need to develop life-saving cancer drugs and research efficiently and expeditiously.
Prior to joining COTA, Sandy was the Senior Vice President of Partnership and Real-World Data at HealthVerity. There she was responsible for driving strategic partner relationships, growing government engagements, and expanding the team that brought real-world data expertise to HealthVerity’s clients.
Before her time with HealthVerity, Sandy was the Vice President, Medical Evidence and Observational Research at AstraZeneca where she led a global team of real-world evidence scientists and study delivery professionals who together delivered impactful evidence for the entirety of the AstraZeneca portfolio.